Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00236-6/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz-9bw1UVy_1zzBvbvdJGtCp4teNLsT82BtqdS00PCHtKnxt3AN6TSCim3vO3Sx4t6iCUyfVkiARLpG8w-tfCYzTkIsQtIg&_hsmi=328184754&utm_content=328157856&utm_source=hs_email